Poland· PL-100525883
Attrogy
A medicinal product containing diflunisalum, registered in Poland by Purpose Pharma International AB.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Diflunisalum
- Manufacturer
- Purpose Pharma International AB
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Diflunisalum in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAttrogyAO Pharma AB
- CzechiaATTROGYPurpose Pharma International AB, Stockholm
- SpainATTROGY 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPurpose Pharma International Ab
- IrelandAttrogy 250 mg film-coated tabletsAO Pharma AB
- IcelandAttrogyPurpose Pharma International AB
- NetherlandsAttrogy 250 mg filmomhulde tablettenAO Pharma AB
- SwedenAttrogy 250 mg Filmdragerad tablettPurpose Pharma International AB
- BelgiumAttrogy 250 mgPurpose Pharma International
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b95caf61-29d4-4428-a3ef-7c6dcb4e5868 GET /v1/drugs/b95caf61-29d4-4428-a3ef-7c6dcb4e5868?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "250 mg",
"packaging": "Rp ¦ EU/1/25/1929/001 ¦ 163953\n100 tabl.",
"substance": "Diflunisalum 250 mg",
"common_name": "Diflunisalum",
"pl_product_id": "100525883",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about diflunisalum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.